Renovorx to participate in the university of cambridge's academy of therapeutic sciences gateway to translation seminar series on june 8, 2022

Los altos, calif.--(business wire)--renovorx, inc. (nasdaq: rnxt), a biopharmaceutical company and innovator in targeted cancer therapy, today announced that it will participate in the gateway to translation webinar series hosted by the university of cambridge's academy of therapeutic sciences (cats) on wednesday, june 8, 2022 at 1:00 pm et. dr. ramtin agah, chief medical officer and co-founder of renovorx, will present a seminar, “localized intra-arterial drug delivery for treatment of solid t
RNXT Ratings Summary
RNXT Quant Ranking